Literature DB >> 11502472

Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice.

M P Akhter1, D M Cullen, G Gong, R R Recker.   

Abstract

Prostaglandins play an important role in regulating the bone adaptation response to mechanical stimuli. Prostaglandin E2 (PGE2) is an effective modulator of bone metabolism. Administration of PGE2 to rodents results in increased cancellous and cortical bone mass translating into enhanced mechanical strength. The PGE2 influence on bone is mediated through four well-characterized receptors (EP1, EP2, EP3, and EP4). Although the PGE2 pathways and mechanisms of action on cells involved in bone adaptation are still under investigation, it is now known that each receptor plays a unique role in regulating PGE2-related bone cell function. The EP1 subtype is coupled with Ca2+ mobilization. The EP2 subtype stimulates cyclic adenosine monophosphate (cAMP) formation. cAMP in turn is responsible for the early cellular signal that stimulates bone formation. This study compared physical and biomechanical properties of bone in EP1 and EP2 knockout mice to their corresponding wild-type controls. Ash weight was measured in the ulnae, and femurs and vertebral bodies were tested in three-point bending and compression, respectively. The results suggest: (a) EP1 receptors have a minimal influence on skeletal strength or size in mice; and (b) EP2 receptors have a major influence on the biomechanical properties of bone in mice. The absence of EP2 receptors resulted in weak bone biomechanical strength properties in the EP2 knockout model as compared with the corresponding wild-type control mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502472     DOI: 10.1016/s8756-3282(01)00486-0

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  28 in total

1.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

Review 2.  Prostaglandin E(2) receptors in bone formation.

Authors:  M Li; D D Thompson; V M Paralkar
Journal:  Int Orthop       Date:  2007-06-26       Impact factor: 3.075

3.  Metabolic and structural bone disturbances induced by hyperlipidic diet in mice treated with simvastatin.

Authors:  Evelise Aline Soares; Rômulo Dias Novaes; Wilson Romero Nakagaki; Geraldo José Medeiros Fernandes; José Antônio Dias Garcia; José Angelo Camilli
Journal:  Int J Exp Pathol       Date:  2015-07-14       Impact factor: 1.925

4.  Effect of hyperlipidemia on femoral biomechanics and morphology in low-density lipoprotein receptor gene knockout mice.

Authors:  Evelise Aline Soares; Wilson Romero Nakagaki; José Antonio Dias Garcia; José Angelo Camilli
Journal:  J Bone Miner Metab       Date:  2012-01-14       Impact factor: 2.626

5.  Determination of Elastic Modulus in Mouse Bones Using a Nondestructive Micro-Indentation Technique Using Reference Point Indentation.

Authors:  Ganesh Thiagarajan; Mark T Begonia; Mark Dallas; Nuria Lara-Castillo; JoAnna M Scott; Mark L Johnson
Journal:  J Biomech Eng       Date:  2018-07-01       Impact factor: 2.097

6.  Fracture healing in mice lacking Pten in osteoblasts: a micro-computed tomography image-based analysis of the mechanical properties of the femur.

Authors:  Caitlyn J Collins; Juan F Vivanco; Scott A Sokn; Bart O Williams; Travis A Burgers; Heidi-Lynn Ploeg
Journal:  J Biomech       Date:  2014-11-28       Impact factor: 2.712

7.  Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats.

Authors:  Mohammad Shahnazari; Wei Yao; WeiWei Dai; Bob Wang; Sophi S Ionova-Martin; Robert O Ritchie; Daniel Heeren; Andrew J Burghardt; Daniel P Nicolella; Michael G Kimiecik; Nancy E Lane
Journal:  Bone       Date:  2009-11-26       Impact factor: 4.398

8.  Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice.

Authors:  Nancy E Lane; Wei Yao; Mehdi Balooch; Ravi K Nalla; Guive Balooch; Stefan Habelitz; John H Kinney; Lynda F Bonewald
Journal:  J Bone Miner Res       Date:  2005-11-14       Impact factor: 6.741

9.  Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.

Authors:  Zheng Xu; Shilpa Choudhary; Yosuke Okada; Olga Voznesensky; Cynthia Alander; Lawrence Raisz; Carol Pilbeam
Journal:  Bone       Date:  2007-03-21       Impact factor: 4.398

10.  Chronic arthritis leads to disturbances in the bone collagen network.

Authors:  Joana Caetano-Lopes; Ana M Nery; Helena Canhão; Joana Duarte; Rita Cascão; Ana Rodrigues; Inês P Perpétuo; Saba Abdulghani; Pedro M Amaral; Shimon Sakaguchi; Yrjö T Konttinen; Luís Graça; Maria F Vaz; João E Fonseca
Journal:  Arthritis Res Ther       Date:  2010-01-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.